Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observation of Treatment Patterns With Lucentis and Real Life Ophthalmic Monitoring, Including Optional OCT in Approved Indications

NCT02194803 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.

NCT NCT02194803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02194803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observation of Treatment Patterns With Lucentis and Real Life Ophthalmic Monitoring, Including Optional OCT in Approved Indications
Lead sponsor
Novartis Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
December 8, 2011
Completion date
December 31, 2016
Enrollment
5,778 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neovascular amd, visual impairment due to dme, visual impairment due to macular oedema secondary to branch or central rvo, visual impairment due to cnv